Swiss National Bank - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 189 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$1,099,008
-26.8%
86,400
-19.0%
0.00%0.0%
Q2 2023$1,502,336
-13.7%
106,700
-5.3%
0.00%0.0%
Q1 2023$1,741,215
+9.7%
112,700
+16.4%
0.00%0.0%
Q4 2022$1,586,552
-9.0%
96,800
+2.8%
0.00%0.0%
Q3 2022$1,743,000
+60.1%
94,200
+13.8%
0.00%0.0%
Q2 2022$1,089,000
+21.4%
82,800
-14.5%
0.00%0.0%
Q1 2022$897,000
+2.5%
96,800
+8.0%
0.00%0.0%
Q4 2021$875,000
-71.3%
89,6000.0%0.00%
-50.0%
Q3 2021$3,045,000
-6.5%
89,600
+0.8%
0.00%0.0%
Q2 2021$3,255,000
-14.2%
88,900
+5.1%
0.00%
-33.3%
Q1 2021$3,793,000
-19.8%
84,600
+2.1%
0.00%0.0%
Q4 2020$4,731,000
+12.1%
82,900
+0.7%
0.00%0.0%
Q3 2020$4,222,000
-10.2%
82,300
+4.6%
0.00%
-25.0%
Q2 2020$4,700,000
+130.6%
78,700
+59.0%
0.00%
+100.0%
Q1 2020$2,038,000
-30.2%
49,500
+5.5%
0.00%
-33.3%
Q4 2019$2,919,000
+88.2%
46,900
+2.6%
0.00%
+50.0%
Q3 2019$1,551,000
+179.5%
45,700
+85.8%
0.00%
+100.0%
Q2 2019$555,000
-12.7%
24,600
-10.2%
0.00%0.0%
Q1 2019$636,000
+14.0%
27,400
+3.0%
0.00%0.0%
Q4 2018$558,000
-43.9%
26,600
+3.5%
0.00%0.0%
Q3 2018$995,000
-1.6%
25,7000.0%0.00%0.0%
Q2 2018$1,011,00025,7000.00%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q4 2020
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$69,030,00015.95%
SV Health Investors, LLC 449,951$25,679,00012.37%
Sunesis Advisors, LLC 96,299$5,496,0004.45%
Redmile Group, LLC 4,437,968$253,275,0003.07%
Consonance Capital Management LP 484,671$27,660,0002.58%
SECTORAL ASSET MANAGEMENT INC 488,842$27,898,0001.97%
Opaleye Management Inc. 222,000$12,670,0001.66%
Eversept Partners, LP 246,240$14,052,9171.65%
SILVERARC CAPITAL MANAGEMENT, LLC 38,620$2,204,0001.28%
Avoro Capital Advisors LLC 1,300,000$74,191,0001.28%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders